WST 240816 350.00C (WST240816C350000) Stock Options, News & Quotes

6.30
+0.60+10.53%

15min DelayClose Jul 24 15:58 ET

6.30High5.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Stock_Drift

Jun 22 15:53

$West Pharmaceutical Services(WST.US)$

Moomoo Recap US

Feb 15 15:36

Columns Wall Street Today | S&P Makes Another Record After Soft Retail Before Inflation Friday

RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US)$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US)$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US)$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US)$ was moderately higher at 15,906, af...

Moomoo AI

Feb 15 09:09

Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.

West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com

Moomoo AI

Feb 11 11:09

Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.

Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies

Moomoo AI

Feb 7 12:02

The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.

West Pharmaceutical Services (NYSE:WST) Jumps 6.8% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns